Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;246(22):2407-2419.
doi: 10.1177/15353702211010415. Epub 2021 Apr 29.

The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport

Affiliations
Review

The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport

Rebecca Siu Ga Tan et al. Exp Biol Med (Maywood). 2021 Nov.

Abstract

The calcium-sensing receptor (CaSR) plays a critical role in sensing extracellular calcium (Ca2+) and signaling to maintain Ca2+ homeostasis. In the parathyroid, the CaSR regulates secretion of parathyroid hormone, which functions to increase extracellular Ca2+ levels. The CaSR is also located in other organs imperative to Ca2+ homeostasis including the kidney and intestine, where it modulates Ca2+ reabsorption and absorption, respectively. In this review, we describe CaSR expression and its function in transepithelial Ca2+ transport in the kidney and intestine. Activation of the CaSR leads to G protein dependent and independent signaling cascades. The known CaSR signal transduction pathways involved in modulating paracellular and transcellular epithelial Ca2+ transport are discussed. Mutations in the CaSR cause a range of diseases that manifest in altered serum Ca2+ levels. Gain-of-function mutations in the CaSR result in autosomal dominant hypocalcemia type 1, while loss-of-function mutations cause familial hypocalciuric hypercalcemia. Additionally, the putative serine protease, FAM111A, is discussed as a potential regulator of the CaSR because mutations in FAM111A cause Kenny Caffey syndrome type 2, gracile bone dysplasia, and osteocraniostenosis, diseases that are characterized by hypocalcemia, hypoparathyroidism, and bony abnormalities, i.e. share phenotypic features of autosomal dominant hypocalcemia. Recent work has helped to elucidate the effect of CaSR signaling cascades on downstream proteins involved in Ca2+ transport across renal and intestinal epithelia; however, much remains to be discovered.

Keywords: Calcium-sensing receptor; FAM111A; calciotropic hormones; calcium homeostasis; calcium transport; intestine; kidney; signaling cascades.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF CONFLICTING INTERESTS: The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Schematic diagram of calcium (Ca2+) homeostasis. Increased plasma Ca2+ activates the calcium-sensing receptor (CaSR; protein structure represented in diagram in purple as a homodimer) in the parathyroid decreasing parathyroid hormone (PTH) release. Decreased PTH release, in addition to CaSR activation in the bone and kidney, results in decreased Ca2+ release from the bone and increased Ca2+ excretion in the urine. Decreased PTH indirectly causes decreased Ca2+ absorption from the small intestine by reducing the kidney production of 1,25-dihydroxyvitamin D (1,25(OH)2VitD). CaSR activation in the small intestine also directly decreases Ca2+ absorption. Overall, increased plasma Ca2+ activates the CaSR in multiple organs decreasing PTH, as well as directly affecting Ca2+ transport in the kidney, bone, and intestine to lower plasma Ca2+ to a normal physiological range (1.1–1.25 mmol/L). (A color version of this figure is available in the online journal.)
Figure 2.
Figure 2.
A schematic representation of calcium-sensing receptor (CaSR) signaling within epithelial cells. The CaSR has an extracellular domain (ECD) containing a Venus fly trap module (VFTM) and a cysteine rich region. It has seven transmembrane domains (TMD) and an intracellular domain (ICD). The CaSR forms homodimers by connection of the VFTMs via disulfide bonds. Calcium (Ca2+) binding within the VFTM activates the CaSR leading to signaling through G alpha (Gα) proteins (Gαq, Gαq11, Gαi, Gα12/13) and beta-arrestin (β-arrestin). Gαq11 stimulates phospholipase C (PLC)-mediated cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) to diacylglycerol (DAG) and inositol 1,4,5, trisphosphate (IP3). IP3 induces release of Ca2+ from the endoplasmic reticulum (ER), thereby increasing cytosolic Ca2+ concentration ([Ca2+]i). DAG activates protein kinase C (PKC) resulting in mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinases (ERK1/2) mediated gene transcription in the nucleus, and in the TAL specifically CLDN14. β-arrestin also stimulates MAPK and ERK1/2. Gαi inhibits adenylate cyclase (AC) and decreases cyclic adenosine monophosphate (cAMP). Gα12/13 activates PLD, which affects cytoskeletal reorganization. Gαq activation of Ras homolog family member A (RhoA) also stimulates cytoskeletal reorganization and gene transcription. (A color version of this figure is available in the online journal.)

References

    1. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366:575–80 - PubMed
    1. Brown EM. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract Res Clin Endocrinol Metab 2013; 27:333–43 - PubMed
    1. Timmers HJ, Karperien M, Hamdy NA, de Boer H, Hermus AR. Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Intern Med 2006; 260:177–82 - PubMed
    1. Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, Viacava P, Naccarato AG, Miccoli P, Kifor O, Brown EM, Pinchera A, Marcocci C. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85:4789–94 - PubMed
    1. Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, Bruneval P, Mandet C, Christensen EI, Faure H, Cheval L, Laghmani K, Collet C, Eladari D, Dodd RH, Ruat M, Houillier P. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012; 122:3355–67 - PMC - PubMed

Publication types

Grants and funding